Clinical trial
Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral…
NCT00254878 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00254878 |
|---|---|
| Title | Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14 |
| Official title | A 7 Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Cross-Over Evaluation of the Efficacy and Safety of Two Different Brands of Modified-Release Oral Dosage Forms of Methylphenidate-HCl (20 mg, q.d.) in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14 |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | ADHD |
| Intervention type | Drug |
| Interventions | Methylphenidate hydrochloride |
| Enrollment | 130 |
| Start date | Oct 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Nov 17, 2005 |
| Last update posted | Dec 21, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: